Evaluation of ADHD from childhood to adolescence- impact of medical treatment on autonomic nervous system parameters

Key information made simple

This study is looking at whether Methylphenidate compared with Atomoxetine can help people with ADHD is a neurobehavioral developmental disorder which affects about 5% of children. In our clinical trial designed we would like to examine whether medical treatment with stimulants has an influen or Children, Adolescents, Under 18. Participants receive one of the study medicines, such as Methylphenidate or Atomoxetine, and complete study visits and assessments. Taking part may give some people access to Methylphenidate compared with Atomoxetine, but direct benefit is not guaranteed.

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.